| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 28.649 | 69.541 | 40.618 | 37.301 |
| Total Income - EUR | - | - | - | - | - | 0 | 28.650 | 73.621 | 40.618 | 37.301 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 11.987 | 62.323 | 43.086 | 90.899 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 0 | 16.663 | 11.299 | -2.468 | -53.597 |
| Net Profit/Loss - EUR | - | - | - | - | - | 0 | 16.402 | 10.648 | -2.882 | -53.597 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sfera Biotech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 103 | 651 | 593 | 512 | 1.994 |
| Current Assets | - | - | - | - | - | 41 | 49.397 | 127.939 | 135.411 | 177.011 |
| Inventories | - | - | - | - | - | 0 | 31.269 | 79.429 | 96.603 | 130.051 |
| Receivables | - | - | - | - | - | 0 | 12.757 | 39.324 | 37.182 | 47.969 |
| Cash | - | - | - | - | - | 41 | 5.370 | 9.186 | 1.626 | -1.009 |
| Shareholders Funds | - | - | - | - | - | 41 | 16.442 | 26.987 | 24.023 | -29.709 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 103 | 36.074 | 101.546 | 111.907 | 208.786 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4685 - 4685" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Sfera Biotech S.r.l.